402
Views
131
CrossRef citations to date
0
Altmetric
Original Article

The Role of CD40–CD154 Interactions in Autoimmunity and the Benefit of Disrupting this Pathway

&
Pages 457-464 | Received 30 Jun 2004, Accepted 08 Jul 2004, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Kerry Jobling & Wan Fai Ng. (2018) CD40 as a therapeutic target in Sjögren’s syndrome. Expert Review of Clinical Immunology 14:7, pages 535-537.
Read now
Matthias Cassia, Federico Alberici, Maurizio Gallieni & David Jayne. (2017) Lupus nephritis and B-cell targeting therapy. Expert Review of Clinical Immunology 13:10, pages 951-962.
Read now
Chunyan Hua, Lin Sun, Yonghong Yang, Renxiang Tan & Yayi Hou. (2013) Mechanisms of CpG-induced CD40 expression on murine bone marrow-derived dendritic cells. Autoimmunity 46:3, pages 177-187.
Read now
Antonios Chatzigeorgiou, Vaggelis Harokopos, Christina Mylona-Karagianni, Emmanouil Tsouvalas, Vassilis Aidinis & Elli Kamper. (2010) The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Annals of Medicine 42:6, pages 426-438.
Read now
Gisela Orozco & Anne Barton. (2010) Update on the genetic risk factors for rheumatoid arthritis. Expert Review of Clinical Immunology 6:1, pages 61-75.
Read now
Gülsüm Emel Pamuk, Ömer Nurı Pamuk, Hüseyın Örüm, Özer Arican, Burhan Turgut & Muzaffer Demır. (2009) Elevated platelet-monocyte complexes ın patıents wıth psorıatıc arthrıtıs. Platelets 20:7, pages 493-497.
Read now
Juan B. de Sanctis, Jenny V. Garmendia, Ricardo Chaurio, Mercedes Zabaleta & Liliana Rivas. (2009) Total and biologically active CD154 in patients with SLE. Autoimmunity 42:4, pages 263-265.
Read now
Adrienn Angyal, József Prechl & Gabriella Sármay. (2007) Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases. Expert Opinion on Biological Therapy 7:5, pages 691-704.
Read now
Janusz Mysliwiec, Magdalena Oklota, Agnieszka Nikolajuk, Dariusz Waligorski & Maria Gorska. (2007) Serum CD40/CD40L System in Graves' Disease and Hashimoto's Thyroiditis Related to Soluble Fas, FasL and Humoral Markers of Autoimmune Response. Immunological Investigations 36:3, pages 247-257.
Read now

Articles from other publishers (122)

Julia-Annabell Georgi, Jan Moritz Middeke, Martin Bornhäuser, Axel Matzdorff & Karolin Trautmann-Grill. (2023) Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP. Blood Advances 7:14, pages 3710-3724.
Crossref
Xinxin Chen, Qingyao Wang, Huanhuan Zang, Xiangguo Cong, Qiong Shen & Lei Chen. (2023) First trimester sCD40L levels associated with adverse neonatal outcomes in euthyroid pregnant women with positive TPOAb. Frontiers in Endocrinology 14.
Crossref
Gisela M. Vaitaitis & David H. WagnerJr.Jr.. (2023) Modulating CD40 and integrin signaling in the proinflammatory nexus using a 15-amino-acid peptide, KGYY15. Journal of Biological Chemistry 299:5, pages 104625.
Crossref
Chayan Acharya, Mats O. Magnusson, Pavan Vajjah, Ruth Oliver & Miren Zamacona. (2023) Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus. The Journal of Clinical Pharmacology 63:4, pages 435-444.
Crossref
Hanna J. Lee, Mihaela Stefan–Lifshitz, Cheuk Wun Li & Yaron Tomer. (2023) Genetics and epigenetics of autoimmune thyroid diseases: Translational implications. Best Practice & Research Clinical Endocrinology & Metabolism 37:2, pages 101661.
Crossref
Ruchi Sachdeva & Rahul Pal. (2022) A pregnancy hormone-cell death link promotes enhanced lupus-specific immunological effects. Frontiers in Immunology 13.
Crossref
Zhen Tan, Li Wang & Xiaomei Li. (2022) Composition and regulation of the immune microenvironment of salivary gland in Sjögren’s syndrome. Frontiers in Immunology 13.
Crossref
Xinxin Chen, Qingyao Wang, Xiangguo Cong, Shuyi Jiang, Shuxiang Li, Qiong Shen & Lei Chen. (2022) sCD40L Is Increased and Associated with the Risk of Gestational Diabetes Mellitus in Pregnant Women with Isolated TPOAb Positivity. International Journal of Endocrinology 2022, pages 1-8.
Crossref
YuXue Nie, Lidan Zhao & Xuan Zhang. (2021) B Cell Aberrance in Lupus: the Ringleader and the Solution. Clinical Reviews in Allergy & Immunology 62:2, pages 301-323.
Crossref
Elizabeth Price. 2022. Handbook of Biologics for Rheumatological Disorders. Handbook of Biologics for Rheumatological Disorders 75 84 .
Pascal Alexander Rabatscher & Marten Trendelenburg. (2022) Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro . Clinical & Translational Immunology 11:8.
Crossref
Fareeha Saadi, Debanjana Chakravarty, Saurav Kumar, Mithila Kamble, Bhaskar Saha, Kenneth S. Shindler & Jayasri Das Sarma. (2021) CD40L protects against mouse hepatitis virus-induced neuroinflammatory demyelination. PLOS Pathogens 17:12, pages e1010059.
Crossref
Tobias Moser, Lena Hoepner, Kerstin Schwenker, Michael Seiberl, Julia Feige, Katja Akgün, Elisabeth Haschke-Becher, Tjalf Ziemssen & Johann Sellner. (2021) Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis. Cells 10:11, pages 3116.
Crossref
Fengping Wu, Jinfang Gao, Jie Kang, Xuexue Wang, Qing Niu, Jiaxi Liu & Liyun Zhang. (2021) B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects. Frontiers in Immunology 12.
Crossref
Elias Manca. (2021) Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease?. Clinical Reviews in Allergy & Immunology 63:2, pages 194-209.
Crossref
Zhimiao Zou, Dunfeng Du, Yan Miao, Yang Yang, Yalong Xie, Zeyang Li, Liang Zhou, Limin Zhang, Ping Zhou & Fengchao Jiang. (2020) TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro. International Immunopharmacology 85, pages 106648.
Crossref
Valentina Pucino, David H Gardner & Benjamin A Fisher. (2020) Rationale for CD40 pathway blockade in autoimmune rheumatic disorders. The Lancet Rheumatology 2:5, pages e292-e301.
Crossref
Kalliopi Klavdianou, Argyro Lazarini & Antonis Fanouriakis. (2020) Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline. BioDrugs 34:2, pages 133-147.
Crossref
Pamela A. McCombe & Judith M. Greer. 2020. The Autoimmune Diseases. The Autoimmune Diseases 419 428 .
Raziel Tapia‐Llanos, José F. Muñoz‐Valle, Ilce V. Román‐Fernández, Miguel Marín‐Rosales, Diana C. Salazar‐Camarena, Alvaro Cruz, Gerardo Orozco‐Barocio, Jorge A. Guareña‐Casillas, Edith Oregon‐Romero & Claudia A. Palafox‐Sánchez. (2019) Association of soluble CD40 levels with ‐1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus . Molecular Genetics & Genomic Medicine 7:12.
Crossref
Hazim Mahmoud Ibrahem. (2019) B cell dysregulation in primary Sjögren’s syndrome: A review. Japanese Dental Science Review 55:1, pages 139-144.
Crossref
Gisela M. Vaitaitis, Martin G. Yussman & David H. WagnerJr.Jr.. (2019) A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 332, pages 8-15.
Crossref
Samuel J. S. Rubin, Michelle S. Bloom & William H. Robinson. (2019) B cell checkpoints in autoimmune rheumatic diseases. Nature Reviews Rheumatology 15:5, pages 303-315.
Crossref
L. V. Putlyaeva, D. E. Demin, K. V. Korneev, A. S. Kasyanov, K. A. Tatosyan, I. V. Kulakovskiy, D. V. Kuprash & A. M. Schwartz. (2019) Potential Markers of Autoimmune Diseases, Alleles rs115662534(T) and rs548231435(C), Disrupt the Binding of Transcription Factors STAT1 and EBF1 to the Regulatory Elements of Human CD40 Gene. Biochemistry (Moscow) 83:12-13, pages 1534-1542.
Crossref
Eun Wha Choi, Kyo Won Lee, Hyojun Park, Hwajung Kim, Jong Hyun Lee, Ji Woo Song, Jehoon Yang, Yeongbeen Kwon, Tae Min Kim, Jae Berm Park & Sungjoo Kim. (2018) Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis. Scientific Reports 8:1.
Crossref
G.H. Frydman, K.A. Metcalf Pate & A. Vitsky. 2018. Comprehensive Toxicology. Comprehensive Toxicology 60 113 .
Soheil Tavakolpour. (2017) Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?. International Immunopharmacology 53, pages 133-142.
Crossref
Jiaxuan Qin, Jinchun Xing, Rongfu Liu, Bin Chen, Yuedong Chen & Xuan Zhuang. (2017) Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis. Oncotarget 8:60, pages 102235-102243.
Crossref
Chris Chamberlain, Peter J Colman, Ann M Ranger, Linda C Burkly, Geoffrey I Johnston, Christian Otoul, Christian Stach, Miren Zamacona, Thomas Dörner, Murray Urowitz & Falk Hiepe. (2017) Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Annals of the Rheumatic Diseases 76:11, pages 1837-1844.
Crossref
Chien-Hsueh Tung, Ming-Chi Lu, Ning-Sheng Lai & Shu-Fen Wu. (2017) Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis. PLOS ONE 12:8, pages e0183726.
Crossref
Yang Xiang, Jing Guo, You-Fan Peng, Hua-Tuo Huang, Yan Lan & Ye-Sheng Wei. (2017) Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population. Rheumatology International 37:8, pages 1287-1294.
Crossref
Julio E. Castañeda-Delgado, Yadira Bastián-Hernandez, Noe Macias-Segura, David Santiago-Algarra, Jose D. Castillo-Ortiz, Ana L. Alemán-Navarro, Pedro Martínez-Tejada, Leonor Enciso-Moreno, Yolanda Garcia-De Lira, Diana Olguín-Calderón, Leendert A. Trouw, Cesar Ramos-Remus & Jose A. Enciso-Moreno. (2017) Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production. Frontiers in Immunology 8.
Crossref
Hanna J. Lee, Angela Lombardi, Mihaela Stefan, Cheuk wun Li, William B. InabnetIIIIII, Randall P. Owen, Erlinda Concepcion & Yaron Tomer. (2017) CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation. Endocrinology 158:2, pages 410-418.
Crossref
Alison Marshall, Antonio Celentano, Nicola Cirillo, Michiko Mirams, Michael McCullough & Stephen Porter. (2017) Immune receptors CD40 and CD86 in oral keratinocytes and implications for oral lichen planus. Journal of Oral Science 59:3, pages 373-382.
Crossref
Peizeng Yang, Hongsong Yu, Bo Lei & Aize Kijlstra. 2017. Advances in Vision Research, Volume I. Advances in Vision Research, Volume I 425 436 .
Tong WuTünde MesterShivani GuptaFengyuan SunTerry J. SmithRaymond S. Douglas. (2016) Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy. Thyroid 26:12, pages 1768-1777.
Crossref
Meriem Bachsais, Nadim Naddaf, Daniel Yacoub, Suzanne Salti, Nada Alaaeddine, Fawzi Aoudjit, Ghada S. Hassan & Walid Mourad. (2016) The Interaction of CD154 with the α5β1 Integrin Inhibits Fas-Induced T Cell Death. PLOS ONE 11:7, pages e0158987.
Crossref
Zoltán Szekanecz, György Kerekes, Edit Végh, Zsófia Kardos, Zsuzsa Baráth, László Tamási & Yehuda Shoenfeld. (2016) Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do. Autoimmunity Reviews 15:7, pages 756-769.
Crossref
Ameet A. Chimote, Peter Hajdu, Leah C. Kottyan, John B. Harley, Yeoheung Yun & Laura Conforti. (2016) Nanovesicle-targeted Kv1.3 knockdown in memory T cells suppresses CD40L expression and memory phenotype. Journal of Autoimmunity 69, pages 86-93.
Crossref
L Cantarini, V Pucino, A Vitale, R Talarico, O M. Lucherini, F Magnotti, V De Rosa, M Galgani, C Alviggi, G MaroneM Galeazzi & G Matarese. (2016) Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens. Clinical and Experimental Immunology 184:2, pages 197-207.
Crossref
Douglas SobelBehrouz AhvaziCarol Pontzer. (2016) The Role of Type I Interferon Subtypes and Interferon-Gamma in Type I Interferon Diabetes Inhibitory Activity in the NOD Mouse. Journal of Interferon & Cytokine Research 36:4, pages 238-246.
Crossref
Antoine Dewitte, Annabelle Tanga, Julien Villeneuve, Sébastien Lepreux, Alexandre Ouattara, Alexis Desmoulière, Christian Combe & Jean Ripoche. (2015) New frontiers for platelet CD154. Experimental Hematology & Oncology 4:1.
Crossref
Anthony Shock, Linda Burkly, Ian Wakefield, Christopher Peters, Ellen Garber, Janine Ferrant, Frederick R. Taylor, Lihe Su, Yen-Ming Hsu, David Hutto, Ali Amirkhosravi, Todd Meyer, John Francis, Sarah Malcolm, Martyn Robinson, Derek Brown, Stevan Shaw, Roland Foulkes, Alastair Lawson, Olivier Harari, Timothy Bourne, Alison Maloney & Neil Weir. (2015) CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study. Arthritis Research & Therapy 17:1.
Crossref
Hanna J. Lee, Cheuk Wun Li, Sara Salehi Hammerstad, Mihaela Stefan & Yaron Tomer. (2015) Immunogenetics of autoimmune thyroid diseases: A comprehensive review. Journal of Autoimmunity 64, pages 82-90.
Crossref
A Tocoian, P Buchan, H Kirby, J Soranson, M Zamacona, R Walley, N Mitchell, E Esfandiari, F Wagner & R Oliver. (2015) First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus. Lupus 24:10, pages 1045-1056.
Crossref
Andreas H. Wagner, Michael Conzelmann, Franziska Fitzer, Thomas Giese, Karsten Gülow, Christine S. Falk, Oliver H. Krämer, Sascha Dietrich, Markus Hecker & Thomas Luft. (2015) JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter. Biochemical Pharmacology 96:1, pages 52-64.
Crossref
Katherine C. Bankert, Kyp L. Oxley, Sonja M. Smith, John P. Graham, Mark de Boer, Marielle Thewissen, Peter J. Simons & Gail A. Bishop. (2015) Induction of an Altered CD40 Signaling Complex by an Antagonistic Human Monoclonal Antibody to CD40. The Journal of Immunology 194:9, pages 4319-4327.
Crossref
Ghada S. Hassan, John Stagg & Walid Mourad. (2015) Role of CD154 in cancer pathogenesis and immunotherapy. Cancer Treatment Reviews 41:5, pages 431-440.
Crossref
Shengping Hou, Aize Kijlstra & Peizeng Yang. 2015. Molecular Biology of Eye Disease. Molecular Biology of Eye Disease 283 298 .
Yong-Rui Zou & Betty Diamond. 2015. Molecular Biology of B Cells. Molecular Biology of B Cells 417 439 .
Chaker Aloui, Antoine Prigent, Caroline Sut, Sofiane Tariket, Hind Hamzeh-Cognasse, Bruno Pozzetto, Yolande Richard, Fabrice Cognasse, Sandrine Laradi & Olivier Garraud. (2014) The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion. International Journal of Molecular Sciences 15:12, pages 22342-22364.
Crossref
Gisela M. Vaitaitis, Michael H. Olmstead, Dan M. Waid, Jessica R. Carter & David H. WagnerJr.Jr.. (2014) A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice. Diabetologia 57:11, pages 2366-2373.
Crossref
Sabine Muth, Kristian Schütze, Tobias Hain, Hideo Yagita, Hansjörg Schild & Hans Christian Probst. (2014) A CD40/CD40L feedback loop drives the breakdown of CD8 + T-cell tolerance following depletion of suppressive CD4 + T cells . European Journal of Immunology 44:4, pages 1099-1107.
Crossref
Xin Gong, Bo Han, Yong Zou, Jiezhong Wang & Wenwei Yang. (2014) Attenuation of Experimental Autoimmune Myocarditis by si-RNA Mediated CD40 Silencing. International Heart Journal 55:6, pages 539-545.
Crossref
Pamela A. McCombe & Judith M. Greer. 2014. The Autoimmune Diseases. The Autoimmune Diseases 319 328 .
Gisela M Vaitaitis & David H Wagner. (2013) CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression. Cellular & Molecular Immunology 10:6, pages 483-489.
Crossref
Ekaterina Alekseevna Sokolova, Nadezhda Alekseevna Malkova, Denis Sergeevich Korobko, Aleksey Sergeevich Rozhdestvenskii, Anastasia Vladimirovna Kakulya, Elena Vladimirovna Khanokh, Roman Andreevich Delov, Fedor Alekseevich Platonov, Tatyana Yegorovna Popova, Elena Gennadievna Aref′eva, Natalia Nikolaevna Zagorskaya, Valentina Mikhailovna Alifirova, Marina Andreevna Titova, Inna Vadimovna Smagina, Svetlana Alksandrovna El′chaninova, Anna Valentinovna Popovtseva, Valery Pavlovich Puzyrev, Olga Georgievna Kulakova, Ekaterina Yur'evna Tsareva, Olga Olegovna Favorova, Sergei Gennadievich Shchur, Natalia Yurievna Lashch, Natalia Fyodorovna Popova, Ekaterina Valerievna Popova, Evgenii Ivanovich Gusev, Aleksey Nikolaevich Boyko, Yurii Sergeevich Aulchenko & Maxim Leonidovich Filipenko. (2013) Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians. PLoS ONE 8:4, pages e61032.
Crossref
P Piotrowski, M Lianeri, M Wudarski, M Olesińska & PP Jagodziński. (2012) Single nucleotide polymorphism of CD40 region and the risk of systemic lupus erythematosus . Lupus 22:3, pages 233-237.
Crossref
Rinkoo Dalan & Melvin Khee Shing Leow. (2012) Immune manipulation for Graves' disease: Re-exploring an unfulfilled promise with modern translational research. European Journal of Internal Medicine 23:8, pages 682-691.
Crossref
Peyman Rajabi, Mahsa Alaee, Kazem Mousavizadeh & Ali Samadikuchaksaraei. (2012) Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis. Inflammation Research 61:12, pages 1347-1354.
Crossref
Mercedes García-Bermúdez, Carlos González-Juanatey, Raquel López-Mejías, María Teruel, Alfonso Corrales, José A. Miranda-Filloy, Santos Castañeda, Alejandro Balsa, Benjamín Fernández-Gutierrez, Isidoro González-Álvaro, Carmen Gómez-Vaquero, Ricardo Blanco, Javier Llorca, Javier Martín & Miguel A. González-Gay. (2012) Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients. PLoS ONE 7:11, pages e49214.
Crossref
Amanda K. Huber, Fred D. Finkelman, Cheuk Wun Li, Erlinda Concepcion, Eric Smith, Eric Jacobson, Rauf Latif, Mehdi Keddache, Weijia Zhang & Yaron Tomer. (2012) Genetically Driven Target Tissue Overexpression of CD40: A Novel Mechanism in Autoimmune Disease. The Journal of Immunology 189:6, pages 3043-3053.
Crossref
Pasquale Esposito, Teresa Rampino, Marilena Gregorini, Elisa Gabanti, Stefania Bianzina & A. Dal Canton. (2012) Mechanisms underlying sCD40 production in hemodialysis patients. Cellular Immunology 278:1-2, pages 10-15.
Crossref
XiaoRi Lian, Rong Xiao, Xinhong Hu, Takuro Kanekura, HongYan Jiang, YaPing Li, YaoYao Wang, Yan Yang, Ming Zhao & QianJin Lu. (2012) DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: A possible explanation for female susceptibility. Arthritis & Rheumatism 64:7, pages 2338-2345.
Crossref
Youssef El Fakhry, Haydar Alturaihi, Daniel Yacoub, Lihui Liu, Wenyan Guo, Claire Leveillé, Daniel Jung, Lara Bou Khzam, Yahye Merhi, John A. Wilkins, Hongmin Li & Walid Mourad. (2012) Functional Interaction of CD154 Protein with α5β1 Integrin Is Totally Independent from Its Binding to αIIbβ3 Integrin and CD40 Molecules. Journal of Biological Chemistry 287:22, pages 18055-18066.
Crossref
Hüseyin Örüm, Gülsüm Emel Pamuk, Ömer Nuri Pamuk, Muzaffer Demir & Burhan Turgut. (2011) Does anti-tnf therapy cause any change in platelet activation in ankylosing spondylitis patients?. Journal of Thrombosis and Thrombolysis 33:2, pages 154-159.
Crossref
Nada Alaaeddine, Ghada S. Hassan, Daniel Yacoub & Walid Mourad. (2012) CD154: An Immunoinflammatory Mediator in Systemic Lupus Erythematosus and Rheumatoid Arthritis. Clinical and Developmental Immunology 2012, pages 1-11.
Crossref
E. M. Kuklina, O. L. Gorbunova & E. N. Smirnova. (2012) Role of CD40-Dependent Signal in Induction of Recombinase RAG-1 Expression in Peripheral T Cells of Patients with Autoimmune Diabetes Mellitus. Bulletin of Experimental Biology and Medicine 152:3, pages 336-339.
Crossref
Dennis WolfJan-David HohmannAnsgar WiedemannKamila BledzkaHermann BlankenbachTimoteo MarchiniKatharina GutteKatharina ZeschkyNicole BasslerNatalie HoppeAlexandra Ortiz RodriguezNadine HerrIngo HilgendorfPeter StachonFlorian WilleckeDaniel DuerschmiedConstantin von zur MuhlenDmitry A. SolovievLi ZhangChristoph BodeEdward F. PlowPeter LibbyKarlheinz PeterAndreas Zirlik. (2011) Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice. Circulation Research 109:11, pages 1269-1279.
Crossref
Christopher M Reilly, Nicole Regna & Nilamadhab Mishra. (2011) HDAC Inhibition in Lupus Models. Molecular Medicine 17:5-6, pages 417-425.
Crossref
Eli C Lewis, Lykke Blaabjerg, Joachim Størling, Sif G Ronn, Paolo Mascagni, Charles A Dinarello & Thomas Mandrup-Poulsen. (2011) The Oral Histone Deacetylase Inhibitor ITF2357 Reduces Cytokines and Protects Islet β Cells In Vivo and In Vitro. Molecular Medicine 17:5-6, pages 369-377.
Crossref
D S Vinay & B S Kwon. (2011) The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases. Clinical and Experimental Immunology 164:2, pages 145-157.
Crossref
J. WANG, W. ZHANG, M.A. NARDI & Z. LI. (2011) HIV‐1 Tat‐induced platelet activation and release of CD154 contribute to HIV‐1‐associated autoimmune thrombocytopenia. Journal of Thrombosis and Haemostasis 9:3, pages 562-573.
Crossref
Antonio Di Sabatino, Laura Rovedatti, Stefania Vetrano, Francesca Vidali, Paolo Biancheri, Maria Rescigno, Silvio Danese, Thomas T MacDonald & Gino R Corazza. (2011) Involvement of CD40–CD40 Ligand in Uncomplicated and Refractory Celiac Disease. American Journal of Gastroenterology 106:3, pages 519-527.
Crossref
Sonia Néron, Philippe J. Nadeau, André Darveau & Jean-François Leblanc. (2011) Tuning of CD40–CD154 Interactions in Human B-Lymphocyte Activation: A Broad Array of In Vitro Models for a Complex In Vivo Situation. Archivum Immunologiae et Therapiae Experimentalis 59:1, pages 25-40.
Crossref
Gisela M. Vaitaitis & David H. WagnerJr.Jr.. (2010) CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity. Molecular Immunology 47:14, pages 2303-2313.
Crossref
Nicola Fagerer & Werner Kullich. (2010) Adipozytokine bei Rheumatoider Arthritis und AdipositasAdipocytokines in rheumatoid arthritis and obesity. Wiener Medizinische Wochenschrift 160:15-16, pages 391-398.
Crossref
Jay Mehta, Anna Genin, Michael Brunner, Lisabeth V. Scalzi, Nilamadhab Mishra, Timothy Beukelman & Randy Q. Cron. (2010) Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis. Arthritis & Rheumatism 62:8, pages 2499-2509.
Crossref
Yu ShiMasahiro FukuokaGuohua LiYouan LiuManyin ChenMichael KonviserXin ChenMary Anne OpavskyPeter P. Liu. (2010) Regulatory T Cells Protect Mice Against Coxsackievirus-Induced Myocarditis Through the Transforming Growth Factor β–Coxsackie-Adenovirus Receptor Pathway. Circulation 121:24, pages 2624-2634.
Crossref
Youssef El Fakhry, Haydar Alturaihi, Djibril Diallo, Yehye Merhi & Walid Mourad. (2010) Critical role of lipid rafts in CD154‐mediated T cell signaling. European Journal of Immunology 40:3, pages 770-779.
Crossref
Claudio Ponticelli & Gabriella Moroni. (2010) Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE). Pharmaceuticals 3:1, pages 300-322.
Crossref
Xiaoyu Zhang, Caroline J. Voskens, Michelle Sallin, Amudhan Maniar, Carolina L. Montes, Yue Zhang, Wei Lin, Guoyan Li, Erin Burch, Ming Tan, Ronna Hertzano, Andrei I. Chapoval, Koji Tamada, Brian R. Gastman, Dan H. Schulze & Scott E. Strome. (2010) CD137 Promotes Proliferation and Survival of Human B Cells. The Journal of Immunology 184:2, pages 787-795.
Crossref
Qu Lin, Zhiming Lin, Jieruo Gu, Feng Huang, Tianwang Li, Qiujing Wei, Zetao Liao, Shuangyan Cao, Yingjuan Jiang & Jinxian Huang. (2009) Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment. Rheumatology International 30:3, pages 317-323.
Crossref
Sonia Néron, Gilles Boire, Nathalie Dussault, Claudia Racine, Artur J. de Brum-Fernandes, Serge Côté & Annie Jacques. (2009) CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro. Archivum Immunologiae et Therapiae Experimentalis 57:6, pages 447-458.
Crossref
Antonios Chatzigeorgiou, Maria Lyberi, Gregorios Chatzilymperis, Adrianos Nezos & Elli Kamper. (2009) CD40/CD40L signaling and its implication in health and disease. BioFactors 35:6, pages 474-483.
Crossref
Anna L. Peters, Laura L. Stunz & Gail A. Bishop. (2009) CD40 and autoimmunity: The dark side of a great activator. Seminars in Immunology 21:5, pages 293-300.
Crossref
Melissa E. Munroe. (2009) Functional roles for T cell CD40 in infection and autoimmune disease: The role of CD40 in lymphocyte homeostasis. Seminars in Immunology 21:5, pages 283-288.
Crossref
M C Levesque. (2009) Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders. Clinical and Experimental Immunology 157:2, pages 198-208.
Crossref
Peter K Gregersen, Chistopher I Amos, Annette T Lee, Yue Lu, Elaine F Remmers, Daniel L Kastner, Michael F Seldin, Lindsey A Criswell, Robert M Plenge, V Michael Holers, Ted R Mikuls, Tuulikki Sokka, Larry W Moreland, S Louis BridgesJrJr, Gang Xie, Ann B Begovich & Katherine A Siminovitch. (2009) REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nature Genetics 41:7, pages 820-823.
Crossref
Daniel I Chasman & Guillaume Paré. (2009) Getting Closer to P-Selectin. Clinical Chemistry 55:6, pages 1051-1052.
Crossref
Grant C. Hughes, David Martin, Kang Zhang, Kelly L. Hudkins, Charles E. Alpers, Edward A. Clark & Keith B. Elkon. (2009) Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Arthritis & Rheumatism 60:6, pages 1775-1784.
Crossref
Raul Elgueta, Micah J. Benson, Victor C. de Vries, Anna Wasiuk, Yanxia Guo & Randolph J. Noelle. (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunological Reviews 229:1, pages 152-172.
Crossref
Abdur Rub, Ranadhir Dey, Meenakshi Jadhav, Rohan Kamat, Santhosh Chakkaramakkil, Subrata Majumdar, Robin Mukhopadhyaya & Bhaskar Saha. (2009) Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nature Immunology 10:3, pages 273-280.
Crossref
Chary López-Pedrera, Nuria Barbarroja & Jose Manuel Villalba. (2009) Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: Genomics and proteomics approaches. PROTEOMICS - CLINICAL APPLICATIONS 3:2, pages 213-225.
Crossref
Eric M. Ruderman & Richard M. Pope. 2009. New Therapeutic Targets in Rheumatoid Arthritis. New Therapeutic Targets in Rheumatoid Arthritis 27 43 .
F. Montecucco & F. Mach. (2008) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 48:1, pages 11-22.
Crossref
Dan M Waid, Gisela M Vaitaitis, Nathan D Pennock & David H Wagner. (2008) Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes. Journal of Leukocyte Biology 84:2, pages 431-439.
Crossref
Roman Puliaev, Irina Puliaeva, Lisbeth A. Welniak, Abigail E. Ryan, Mark Haas, William J. Murphy & Charles S. Via. (2008) CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus. The Journal of Immunology 181:1, pages 47-61.
Crossref
Gisela M. Vaitaitis & David H. Wagner. (2008) High Distribution of CD40 and TRAF2 in Th40 T Cell Rafts Leads to Preferential Survival of this Auto-Aggressive Population in Autoimmunity. PLoS ONE 3:4, pages e2076.
Crossref
Brian Zarnegar, Soh Yamazaki, Jeannie Q. He & Genhong Cheng. (2008) Control of canonical NF-κB activation through the NIK–IKK complex pathway. Proceedings of the National Academy of Sciences 105:9, pages 3503-3508.
Crossref
Kosmas I. Paraskevas. (2007) Statin treatment for rheumatoid arthritis: a promising novel indication. Clinical Rheumatology 27:3, pages 281-287.
Crossref
Ling Li, Houping Wang & Bin Wang. (2008) Anergic cells generated by blocking CD28 and CD40 costimulatory pathways in vitro ameliorate collagen induced arthritis. Cellular Immunology 254:1, pages 39-45.
Crossref
Terry J Smith. (2007) Is a common therapy for autoimmune disease possible?. Future Rheumatology 2:4, pages 333-335.
Crossref
Melissa E. Munroe, Jack L. Arbiser & Gail A. Bishop. (2007) Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis. The Journal of Immunology 179:2, pages 753-763.
Crossref
Andreas ZirlikUdo BavendiekPeter LibbyLindsey MacFarlaneNorbert GerdesJoanna JagielskaSandra ErnstMasanori AikawaHiroyasu NakanoErdyni TsitsikovUwe Schönbeck. (2007) TRAF-1, -2, -3, -5, and -6 Are Induced in Atherosclerotic Plaques and Differentially Mediate Proinflammatory Functions of CD40L in Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology 27:5, pages 1101-1107.
Crossref
Claire Lé;veillé;Marlène Bouillon, Wen Guo, Julie Bolduc, Ehssan Sharif-Askari, Youssef El-Fakhry, Carlos Reyes-Moreno, Rejean Lapointe, Yahye Merhi, John A. Wilkins & Walid Mourad. (2007) CD40 Ligand Binds to α5β1 Integrin and Triggers Cell Signaling. Journal of Biological Chemistry 282:8, pages 5143-5151.
Crossref
Melissa E. Munroe & Gail A. Bishop. (2007) A Costimulatory Function for T Cell CD40. The Journal of Immunology 178:2, pages 671-682.
Crossref
X Li, V RiderB F Kimler & N I Abdou. (2016) Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells. Lupus 15:12, pages 852-857.
Crossref
Takeshi TSUBATA. (2006) B-cell abnormality and systemic lupus erythematosus. APLAR Journal of Rheumatology 9:4, pages 372-376.
Crossref
Martin J. Richer, Dianne Fang, Iryna Shanina & Marc S. Horwitz. (2006) Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-β in coxsackievirus-mediated autoimmune myocarditis. Clinical Immunology 121:3, pages 339-349.
Crossref
A K Stoeckman, E C Baechler, W A Ortmann, T W Behrens, C J Michet & E J Peterson. (2006) A distinct inflammatory gene expression profile in patients with psoriatic arthritis. Genes & Immunity 7:7, pages 583-591.
Crossref
Chongmin Huan, Matthew L Kelly, Ryan Steele, Iuliana Shapira, Susan R S Gottesman & Christopher A J Roman. (2006) Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity. Nature Immunology 7:10, pages 1082-1091.
Crossref
Robin Lesley, Lisa M. Kelly, Ying Xu & Jason G. Cyster. (2006) Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proceedings of the National Academy of Sciences 103:28, pages 10717-10722.
Crossref
S Patschan, S Dolff, A Kribben, J Dürig, D Patschan, B Wilde, C Specker, T Philipp & O Witzke. (2006) CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 145:2, pages 235-242.
Crossref
Karin Loser, Sandra Balkow, Tetsuya Higuchi, Jenny Apelt, Annegret Kuhn, Thomas A. Luger & Stefan Beissert. (2006) FK506 Controls CD40L-Induced Systemic Autoimmunity in Mice. Journal of Investigative Dermatology 126:6, pages 1307-1315.
Crossref
Yu Zhu, Joseph Antony, Shuhong Liu, Jose A. Martinez, Fabrizio Giuliani, Douglas Zochodne & Christopher Power. (2006) CD8+ Lymphocyte-Mediated Injury of Dorsal Root Ganglion Neurons during Lentivirus Infection: CD154-Dependent Cell Contact Neurotoxicity. The Journal of Neuroscience 26:13, pages 3396-3403.
Crossref
René Westhovens. (2006) Abatacept: the first-in-class costimulation blocker for the treatment of rheumatoid arthritis. Future Rheumatology 1:1, pages 15-22.
Crossref
Claire Arnaud & François Mach. (2006) Potential antiinflammatory and immunomodulatory effects of statins in rheumatologic therapy. Arthritis & Rheumatism 54:2, pages 390-392.
Crossref
Johan Frostegård. (2005) Atherosclerosis in Patients With Autoimmune Disorders. Arteriosclerosis, Thrombosis, and Vascular Biology 25:9, pages 1776-1785.
Crossref
Ora Shovman, Gisele Zandman-Goddard, Yaniv Sherer, Boris Gilburd & Yehuda Shoenfeld. (2005) Immune tolerance as a strategy for treatment of atherosclerosis. Drug Discovery Today: Therapeutic Strategies 2:3, pages 207-211.
Crossref
Randy Q. Cron. (2005) A signal achievement in the treatment of arthritis. Arthritis & Rheumatism 52:8, pages 2229-2232.
Crossref
Andrea Doria, Yaniv Sherer, Pier L. Meroni & Yehuda Shoenfeld. (2005) Inflammation and Accelerated Atherosclerosis: Basic Mechanisms. Rheumatic Disease Clinics of North America 31:2, pages 355-362.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.